Division of Pulmonary & Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
Division of Pulmonary & Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
J Heart Lung Transplant. 2021 Oct;40(10):1212-1222. doi: 10.1016/j.healun.2021.06.016. Epub 2021 Jul 10.
Mechanical ventilation immediately after lung transplantation may impact the development of primary graft dysfunction (PGD), particularly in cases of donor-recipient size mismatch as ventilation is typically based on recipient rather than donor size.
We conducted a retrospective cohort study of adult bilateral lung transplant recipients at our center between January 2010 and January 2017. We defined donor-based lung protective ventilation (dLPV) as 6 to 8 ml/kg of donor ideal body weight and plateau pressure <30 cm HO. We calculated the donor-recipient predicted total lung capacity (pTLC) ratio and used logistic regression to examine relationships between pTLC ratio, dLPV and PGD grade 3 at 48 to 72 hours. We used Cox proportional hazards modelling to examine the relationship between pTLC ratio, dLPV and 1-year survival.
The cohort included 373 recipients; 24 (6.4%) developed PGD grade 3 at 48 to 72 hours, and 213 (57.3%) received dLPV. Mean pTLC ratio was 1.04 ± 0.18. dLPV was associated with significantly lower risks of PGD grade 3 (OR = 0.44; 95% CI: 0.29-0.68, p < 0.001) and 1-year mortality (HR = 0.49; 95% CI: 0.29-0.8, p = 0.018). There was a significant association between pTLC ratio and the risk of PGD grade 3, but this was attenuated by the use of dLPV.
dLPV is associated with decreased risk of PGD grade 3 at 48 to 72 hours and decreased 1-year mortality. Additionally, dLPV attenuates the association between pTLC and both PGD grade 3 and 1-year mortality. Donor-based ventilation strategies may help to mitigate the risk of PGD and other adverse outcomes associated with size mismatch after lung transplantation.
肺移植后立即进行机械通气可能会影响原发性移植物功能障碍(PGD)的发展,特别是在供体-受者大小不匹配的情况下,因为通气通常基于受者而不是供者的大小。
我们对 2010 年 1 月至 2017 年 1 月在我们中心进行的成人双侧肺移植受者进行了回顾性队列研究。我们将基于供体的肺保护性通气(dLPV)定义为 6 至 8ml/kg 供体理想体重和平台压<30cmHO。我们计算了供体-受者预测总肺容量(pTLC)的比值,并使用逻辑回归分析了 pTLC 比值、dLPV 和 48 至 72 小时时 PGD 3 级之间的关系。我们使用 Cox 比例风险模型分析了 pTLC 比值、dLPV 和 1 年生存率之间的关系。
该队列包括 373 名受者;24 名(6.4%)在 48 至 72 小时时发生 PGD 3 级,213 名(57.3%)接受了 dLPV。平均 pTLC 比值为 1.04±0.18。dLPV 与 PGD 3 级(OR=0.44;95%CI:0.29-0.68,p<0.001)和 1 年死亡率(HR=0.49;95%CI:0.29-0.8,p=0.018)的风险显著降低相关。pTLC 比值与 PGD 3 级风险之间存在显著关联,但 dLPV 的使用减轻了这种关联。
dLPV 与 48 至 72 小时时 PGD 3 级风险降低和 1 年死亡率降低相关。此外,dLPV 减轻了 pTLC 与 PGD 3 级和 1 年死亡率之间的关联。基于供体的通气策略可能有助于减轻肺移植后大小不匹配引起的 PGD 和其他不良结局的风险。